Responses
Regular and young investigator award abstracts
Immune-stimulants and immune modulators
569 Targeting IL-15 delivery to PD-L1 expressing tumors with an Anti-PD-L1-IL-15 cytokine fusion IgM to enhance T Cell and NK Cell Mediated tumor cytotoxicity
Compose a Response to This Article
Other responses
No responses have been published for this article.